Hematology Home >
- Faculty
Edward A. Stadtmauer, MDProfessor of Medicine at the Hospital of the University of Pennsylvania
Co-Leader, Hematologic Malignancies Program
Associate Director for Clinical Services and Programs
Department: Medicine
Contact information
2 Perelman Center for Advanced Medicine
34th and Civic Center Bld 2-319S Philadelphia, PA 19104
Office: 2156627910
Fax: 215-662-4064 Email: stadtmae@uphs.upenn.edu
Education:
A.B. (Biochemistry) Cornell University, College of Arts and Sciences, 1979. M.D. (Medicine) University of Pennsylvania School of Medicine, 1983.
Post-Graduate Training
Intern, Internal Medicine, Bronx Muncipal Hospital, Albert Einstein College of Medicine, Bronx, NY, 1983-1984. Resident, Internal Medicine, Bronx Muncipal Hospital, Albert Einstein College of Medicine, Bronx, NY, 1984-1986. Fellowship, Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, 1986-1989.
Certifications
Permanent linkInternal Medicine, 1986. Hematology, 1988. Medical Oncology, 1989. Description of Research ExpertiseClinical trials, Bone Marrow TransplantDescription of Clinical ExpertiseMyeloma, Leukemia, Bone Marrow and Stem Cell Transplant, LymphomaSelected PublicationsEdward A. Stadtmauer: Autologous Transplantation of Hematopoietic Stem Cells (Chapter 95). Clinical Hematology. Neal S. Young, Stanton L. Gerson, and Katherine A. High (eds.). Elsevier, Inc (Mosby), 2006.Richardson PG., Sonneveld P., Schuster MW., Irwin D., Stadtmauer EA.: Bortezomib or high-dose dexamethasone for relapsed multiple myeloma.[see. New England Journal of Medicine 352(24): 2487-98, Jun 16 2005. Cassileth PA., Lee SJ., Litzow MR., Miller KB., Stadtmauer EA., Tallman: Intensified induction chemotherapy in adult acute myeloid leukemia. Leukemia & Lymphoma 46(1): 55-61, Jan 2005. Loren AW., Luger SM., Stadtmauer EA., Tsai DE., Schuster S., Nasta SD., Goldstein SC., Perl A., Orloff G., Oliver JC., Green J., Emerson SG., Porter DL.: Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation. Bone Marrow Transplantation 35(9): 921-6, May 2005. Vogl DT., Glatstein E., Carver JR., Schuster SJ., Stadtmauer EA., Luger S., Nasta SD., Porter DL., Elstrom R., Tsai DE.: Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation. Leukemia & Lymphoma 46(9): 1313-20, Sep 2005. Larson RA., Sievers EL., Stadtmauer EA., Lowenberg B., Estey EH., Dombret H., Theobald M., Voliotis D., Bennett JM., Richie M., Leopold LH., Berger MS., Sherman ML., Loken MR., van Dongen JJ., Bernstein ID., Appelbaum FR.: Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence. Cancer 104(7): 1442-52, Oct 1 2005. Rapoport AP., Stadtmauer EA., Aqui N., Badros A., Cotte J., Chrisley L., Veloso E., Zheng Z., Westphal S., Mair R., Chi N., Ratterree B., Pochran MF., Natt S., Hinkle J., Sickles C., Sohal A., Ruehle K., Lynch C., Zhang L., Porter DL., Luger S., Guo C., Fang HB., Blackwelder W., Hankey K., Mann D., Edelman R., Frasch C., Levine BL., Cross A., June CH.: Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer. Nature Medicine 11(11): 1230-7, Nov 2005. Tsai DE., Aqui NA., Tomaszewski JE., Olthoff KM., Ahya VN., Kotloff RM., Bloom RD., Brozena SC., Hodinka RL., Stadtmauer EA., Schuster SJ., Nasta SD., Porter DL., Luger SM., Klumpp TR.: Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorder. Clinical Transplantation 19(5): 644-52, Oct 2005. S. Jagannath, P. G. Richardson, P. Sonneveld, D. Irwin, M. W. Schuster, E. A. Stadtmauer, T. Facon, J. L. Harousseau, J. M. Cowan, K. C. Anderson.: Bortezomib appears to overcome poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials. Proceedings ASCO 24: 6501a, June 2005 Notes: (Oral Presentation).
|
